OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $65,000 | -66.7% | 115,435 | +1.6% | 0.00% | -100.0% |
| Q4 2015 | $195,000 | -2.5% | 113,660 | +19.9% | 0.00% | 0.0% |
| Q3 2015 | $200,000 | -57.8% | 94,805 | -1.0% | 0.00% | -50.0% |
| Q2 2015 | $474,000 | -50.6% | 95,776 | -21.9% | 0.00% | -33.3% |
| Q1 2015 | $960,000 | +55.3% | 122,636 | +20.3% | 0.00% | +50.0% |
| Q4 2014 | $618,000 | +50.4% | 101,911 | +5.7% | 0.00% | +100.0% |
| Q3 2014 | $411,000 | -33.7% | 96,436 | -3.9% | 0.00% | -50.0% |
| Q2 2014 | $620,000 | +9.5% | 100,391 | +15.2% | 0.00% | 0.0% |
| Q1 2014 | $566,000 | +15.5% | 87,127 | +0.0% | 0.00% | +100.0% |
| Q4 2013 | $490,000 | -10.1% | 87,087 | -1.8% | 0.00% | -50.0% |
| Q3 2013 | $545,000 | +6.9% | 88,707 | +1.8% | 0.00% | 0.0% |
| Q2 2013 | $510,000 | – | 87,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $8,125,000 | 5.71% |
| Rock Springs Capital Management LP | 830,000 | $5,395,000 | 1.24% |
| First Light Asset Management, LLC | 195,359 | $1,270,000 | 0.90% |
| Palo Alto Investors LP | 3,338,048 | $21,698,000 | 0.90% |
| Rhenman & Partners Asset Management AB | 329,199 | $2,140,000 | 0.64% |
| NEA Management Company, LLC | 1,935,300 | $12,579,000 | 0.62% |
| PFM Health Sciences, LP | 5,129,129 | $33,339,000 | 0.60% |
| Sivik Global Healthcare LLC | 124,145 | $807,000 | 0.50% |
| QVT Financial LP | 1,322,729 | $8,598,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 433,657 | $2,819,000 | 0.41% |